Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
26-29 March, 2025
Not Confirmed
Not Confirmed
27-29 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
26-29 March, 2025
Industry Trade Show
Not Confirmed
27-29 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
29 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/29/2937696/0/en/Notable-Labs-to-Present-Data-on-September-4th-at-SOHO-2024.html
26 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/26/2935803/0/en/Notable-Labs-Announces-CEO-Transition.html
24 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/24/2917910/0/en/Notable-Labs-Receives-FDA-Clearance-to-Proceed-Further-with-Volasertib-Phase-2-Study.html
09 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/09/2879200/0/en/Notable-Labs-to-Participate-in-Fireside-Chat-at-the-Citizens-JMP-Securities-Life-Sciences-Conference-2024.html
12 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/12/2862139/0/en/Notable-Labs-Reports-2023-Financial-Results-and-Provides-a-Business-Update.html
09 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/09/2860412/0/en/Notable-Labs-Presents-the-Design-Plan-for-the-PPMP-Enabled-Phase-2-Trial-with-Volasertib-for-Relapsed-Refractory-AML-at-AACR-2024.html
ABOUT THIS PAGE